Entyvio (Vedolizumab) Long-term Safety Study: An International Observational Prospective Cohort Study Comparing Vedolizumab to Other Biologic Agents in Patients With Ulcerative Colitis or Crohn's Disease
Entyvio (Vedolizumab) Long-term Safety Study: An International Observational Prospective Cohort Study Comparing Vedolizumab to Other Biologic Agents in Patients With Ulcerative Colitis or Crohn's Disease
The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis (UC) or Crohn's Disease (CD).
The drug being tested in this prospective, observational study is called vedolizumab. Vedolizumab is being used to treat people who have UC or CD. This study will look at the long-term safety of vedolizumab versus other biologic agents in participants with UC or CD. The study will enroll approximately 5000 participants. All participants enrolled in this will belong to one of the two treatment group:
Golimumab and infliximab. Study drugs will be prescribed by the physician according to local prescribing information in the participating countries. This multi-centre trial will be conducted worldwide. The overall time to participate in this study is 7 years. Participants will make visits at every 6 months to their treating physician.
Inclusion Criteria:
Exclusion Criteria:
Arlington Heights, Illinois 60005, United States
Boston, Massachusetts 02118, United States
Ocean Spring, Mississippi 39564, United States
Oberosterreich, 4020, Austria
Vienna, 1090, Austria
Liège, 4000, Belgium
Copenhagen NV, 2400, Denmark
Caen, 14033, France
Lille, 59037, France
Nice, 06202, France
Pessac, 33604, France
Pierre-Bénite, 69495, France
Valenciennes, 59322, France
Berlin, 12203, Germany
Berlin, 13353, Germany
DESSAU-ROsLAU, 06847, Germany
Dresden, 01307, Germany
Hamburg Eppendorf, 20251, Germany
Zrifin, 70300, Israel
Avellino Campania, 83100, Italy
Nordbyhagen, 1478, Norway
Hospitalet, 08907, Spain
Bern, 3010, Switzerland
Bern, 3012, Switzerland
Coventry, CV2 2DX, United Kingdom
Derby, DE22 3NE, United Kingdom
Harrow, HA1 3UJ, United Kingdom
Nottingham, NG7 2UH, United Kingdom
Sheffield, S10 2JF, United Kingdom
Shrewsbury, SY3 8XQ, United Kingdom
Wolverhampton, WV6 9AT, United Kingdom